Hematology

Point of care hemoglobin analyzers

EKF Hematology division aims to make blood donation and anemia screening easier, more affordable and more accessible than ever before.

Our point of care hemoglobin analyzers and tests deliver fast and reliable results for hemoglobin and hematocrit that provide both practitioner and patient with helpful information to guide decisions for medical care or lifestyle interventions in seconds.

All over the world our hemoglobin analyzers are used in blood banks, field clinics, malnutrition and HIV programs, GP surgeries, obstetrics and maternity wards.

EKF hemoglobin analyzers make blood donation and anemia screening easier

Our analyzers

Hemo Control

The point of care hemoglobin analyzer Hemo Control uses the most established azide methemoglobin method to deliver accurate hemoglobin results, as well as an optional hematocrit calculation, from 25 seconds.

DiaSpect Tm and DiaSpect T Low

The DiaSpect point of care hemoglobin analyzers, Diaspect Tm for whole blood and Diaspect T Low for plasma, use a reagentless cuvette to provide results in approximately one second. Reagentless cuvettes have a long shelf life and are ideally suited to hot and humid conditions.

HemataStat II

The HemataSTAT II is a point of care microhematocrit centrifuge that provides quantitative readings for multiple patient samples. HemataStat II is ideally suited for use within laboratories and veterinary settings.

View the range

HemataStat II

The world’s leading microhematocrit centrifuge - Quickly measures hematocrit in any setting

Hemo Control

Hemoglobin and hematocrit analyzer - Simple, accurate and reliable test

DiaSpect Tm

Hand-held hemoglobin analyzer - The world's fastest hemoglobin analyzer

DiaSpect Hemoglobin T Low

Precise plasma hemoglobin measurement in less than two seconds

Point of care hemoglobin analyzers more affordable and accessible than ever before.

Read our guides

We have written a series of guides to help medical professionals understand more about point-of-care testing for anemia, diabetes, ketosis and lactate measurement.

Find out more about the different methods for testing, the symptoms, the associated conditions and understand how POCT can help deliver accurate results in minutes.

Read guides

Anemia and hemoglobin testing

Read more about anemia and hemoglobin testing.

Diabetes and HbA1c testing

Capillary sampling guide

Read more about the importance of capillary blood sampling.

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF to highlight Lucica® Glycated Albumin-L assay for diabetes patient monitoring at AACC 2019

EKF announces the availability of a liquid, enzymatic test for glycated albumin (GA) that was recently FDA cleared for sales in the U.S. GA, used for intermediate term monitoring of glycemic control in diabetes patients, will be showcased at the 2019 AACC.

EKF at InterLab - Algiers, Algeria 2019

The third edition of the exhibition will be held on 25-27 September 2019 at the Palais des Expositions, SAFEX, Algiers, Algeria.

EKF Quo-Test supports improved medical management of diabetic retinopathy patients

Quo-Test^® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening diabetic retinopathy (STDR).

SensLab is sponsoring the 36th Leipzig Triathlon

SensLab, an EKF Diagnostics company, will be testing triathletes lactate levels at the 36^th Leipzig Triathlon to be held at Kulkwitzer on the 28^th July 2019.

Bugs Runny: New study identifies bugs that help runners

A recent article in Nature Medicine by Scheiman et al has identified a strain of gut microbes present in marathon runners that improves run times. The scientists at Harvard and the Joslin Institute took poop samples from 15 runners at the 2015 Boston marathon.